The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sapirstein James since 2015.
This trader's CIK number is 1559509.
At the time of last reporting, Sapirstein James was the Chairman and CEO of Entero Therapeutics, Inc.. (stock ticker symbol ENTO).
Also see all insider trading activities at Entero Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | CTRV | 10,000 | $10,000 | 0 | $0 | 16,666 | $24,999 |
| 2015 | CTRV | 3,000 | $5,175 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ENTO | 0 | $0 | 3,516 | $12,170 | 0 | $0 |
| 2023 | ENTO | 0 | $0 | 9,460 | $14,325 | 0 | $0 |
1. Hepion Pharmaceuticals, Inc. (CTRV)
2. Entero Therapeutics, Inc. (ENTO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-10-27 | CTRV | Option Ex | 16,666 | 1.50 | 24,999 |
| 2016-02-18 | CTRV | Buy | 10,000 | 1.00 | 10,000 |
| 2015-11-30 | CTRV | Buy | 500 | 2.15 | 1,075 |
| 2015-11-23 | CTRV | Buy | 2,500 | 1.64 | 4,100 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-02 | ENTO | Sale | 1,289 | 1.07 | 1,379 |
| 2024-04-01 | FWBI | Sale | 174 | 4.23 | 735 |
| 2024-03-15 | FWBI | Sale | 1,887 | 4.96 | 9,359 |
| 2024-01-12 | FWBI | Sale | 166 | 4.20 | 697 |
| 2023-10-04 | FWBI | Sale | 2,764 | .29 | 801 |
| 2023-07-03 | FWBI | Sale | 3,349 | 1.54 | 5,157 |
| 2023-04-03 | FWBI | Sale | 3,347 | 2.50 | 8,367 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sapirstein James (Chairman and CEO of Entero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.